StockOtters
StockOttersSupply Chain Map
Sino Biopharmaceutical Limited logo

Sino Biopharmaceutical Limited

1177.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
3,753
Cost of Revenue
694
Gross Profit
3,059
Gross Margin
81.5%
Operating Income
798
Operating Margin
21.3%
Net Income
455
Net Margin
12.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
794
EBITDA Margin
21.2%

2023

12/31/2023

Revenue
3,406
Cost of Revenue
649
Gross Profit
2,757
Gross Margin
81.0%
Operating Income
752
Operating Margin
22.1%
Net Income
303
Net Margin
8.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
907
EBITDA Margin
26.6%

2022

12/31/2022

Revenue
3,383
Cost of Revenue
753
Gross Profit
2,800
Gross Margin
82.8%
Operating Income
726
Operating Margin
21.5%
Net Income
331
Net Margin
9.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
870
EBITDA Margin
25.7%

2021

12/31/2021

Revenue
3,492
Cost of Revenue
693
Gross Profit
2,799
Gross Margin
80.1%
Operating Income
660
Operating Margin
18.9%
Net Income
1,899
Net Margin
54.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
2,584
EBITDA Margin
74.0%

2020

12/31/2020

Revenue
3,074
Cost of Revenue
674
Gross Profit
2,400
Gross Margin
78.1%
Operating Income
545
Operating Margin
17.7%
Net Income
360
Net Margin
11.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
736
EBITDA Margin
23.9%